The human placenta contains kappa opioid receptors that regulate key pregnancy hormones and may influence fetal growth.
Only kappa receptorsThe placenta exclusively expresses kappa opioid receptors — no mu or delta types were detected
What the researchers found
Human placenta contains exclusively kappa opioid receptors (MW ~63,000). They regulate acetylcholine and hCG/placental lactogen release. Receptor numbers correlate with birth weight at term.
Why it matters
The placenta has its own opioid system that influences pregnancy hormones and fetal growth. This has implications for how opioid drugs during pregnancy might affect the baby.
How the study worked
Review of studies on human placental villus tissue including receptor binding, purification, functional assays, and correlations with pregnancy outcomes.
What this study cannot tell us
Review based on in vitro placental tissue studies. Functional significance in vivo may differ. Only kappa receptors were found, but detection methods from 1992 may have missed very low levels of other types.
How to read the evidence
Moderate — a review article synthesizing in vitro placental studies. Provides consistent evidence but lacks in vivo confirmation.
When this study was published
Published in 1992 (34 years ago). Receptor detection methods have improved significantly since then.
The bigger picture
Understanding the placenta's own opioid system helps explain how opioid drugs taken during pregnancy might interfere with normal hormonal regulation and fetal growth — relevant to the opioid crisis's impact on newborns.
Questions still open
- Could targeting placental kappa receptors help manage pregnancy complications?
- How do exogenous opioids disrupt this natural placental opioid signaling?
Common questions
Why does the placenta have opioid receptors?
Could opioid drugs affect the placenta?
Read the original research
Properties and functions of human placental opioid system.
Life sciences, 50(2), 83-97
Citation
Ahmed, M S; Cemerikic, B; Agbas, A. (1992). Properties and functions of human placental opioid system.. Life sciences, 50(2), 83-97.